Jeffrey S. Freeman, James R. Gavin, Craig W. Spellman. Common Patient Concerns About the Use of Glucagon-like Peptide-1 Receptor Agonists in Diabetes Mellitus Management. J Am Osteopath Assoc 2012;112(1_suppl_1):S22–S24. doi: .
Download citation file:
The authors present a case of a 46-year-old woman with type 2 diabetes mellitus who has been on a treatment regimen involving diet, exercise, and metformin. After 2 years of treatment, she has a body mass index of 35 and a glycosylated hemoglobin level of 8.0%, and this level is increasing. Her physician recommends adding a glucagon-like peptide-1 (GLP-1) receptor agonist to her treatment regimen, prompting her to ask several questions. The authors present these questions along with proposed answers, highlighting the practical application of GLP-1 receptor agonists in the context of common patient concerns.
This PDF is available to Subscribers Only
View Article Abstract & Purchase Options